Tirzepatide 15 mg
- Batch
- Tirz-15
- Analysis date
- June 23, 2026
- Tirzepatide content
- 17.37 mg
- Purity
- 99.685%
Third-party analytical documentation
COA & test report library
Search 24 uploaded reports by product, reported batch, or laboratory task number. Open any record to review the full original report and the values shown by the testing laboratory.
24 reports24 products1 searchable library
Tesamorelin 20 mg
- Batch
- Tes-20
- Analysis date
- May 13, 2026
- Tesamorelin content
- 22.59%
- Purity
- 98.472%
SS-31 10 mg
- Batch
- S-10
- Analysis date
- June 19, 2026
- SS-31 content
- 13.72%
- Purity
- 99.634%
MT2 10 mg
- Batch
- Mt-10
- Analysis date
- May 28, 2026
- Melanotan 2 content
- 10.01 mg
- Purity
- 99.719%
TB-500 5 mg
- Batch
- Tb-5
- Analysis date
- May 28, 2026
- TB-500 (TB4) content
- 5.51 mg
- Purity
- 99.171%
Semaglutide 15 mg
- Batch
- Sema-15
- Analysis date
- May 27, 2026
- Semaglutide content
- 15.23%
- Purity
- 99.262%
Semax 10 mg
- Batch
- Semax-10
- Analysis date
- April 23, 2026
- N-Acetyl Semax Amidate content
- 13.08 mg
- Purity
- 99.563%
Selank 10 mg
- Batch
- Not listed
- Analysis date
- March 17, 2026
- Selank content
- 11.55 mg
- Purity
- 99.793%
Glutathione 1,500 mg
- Batch
- 2026
- Analysis date
- May 20, 2026
- Glutathione content
- 1529.69 mg
- Purity
- 99.052%
KLOW 80 mg
- Batch
- 2025-11
- Analysis date
- November 13, 2025
- GHK-Cu content
- 71.36 mg
- BPC-157 content
- 12.41 mg
- TB-500 (TB4) content
- 11.12 mg
- KPV content
- 11.75 mg
- Purity
- Not separately reported
BPC-157 10 mg + TB-500 10 mg
- Batch
- BB2020CP
- Analysis date
- May 26, 2026
- TB-500 (889 Da) content
- 11.14 mg
- BPC-157 content
- 11.32 mg
- Purity
- Not separately reported
MOTS-C 20 mg
- Batch
- MC-20
- Analysis date
- June 22, 2026
- MOTS-C content
- 23.38 mg
- Purity
- 99.198%
NAD+ 1,000 mg
- Batch
- Nad-1000
- Analysis date
- May 15, 2026
- NAD+ content
- 929.05 mg
- Purity
- Not separately reported
CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg
- Batch
- CP-10
- Analysis date
- March 17, 2026
- CJC-1295 (mod GRF 1-29) content
- 7.27 mg
- Ipamorelin content
- 5.97 mg
- Purity
- Not separately reported
Epitalon 10 mg
- Batch
- 4
- Analysis date
- June 4, 2026
- Epithalon content
- 15.69%
- Purity
- 99.623%
Ipamorelin 10 mg
- Batch
- 24th April 2026
- Analysis date
- May 19, 2026
- Ipamorelin content
- 9.46 mg
- Purity
- 99.942%
GHK-Cu 50 mg
- Batch
- 2026
- Analysis date
- May 20, 2026
- GHK content
- 44.74 mg
- Cu content
- 1.87 mg
- Purity
- 99.453%
Retatrutide 20 mg
- Batch
- 2026
- Analysis date
- May 11, 2026
- Retatrutide content
- 22.99 mg
- Purity
- 99.576%
5-Amino-1MQ 50 mg
- Batch
- 5-amino-50
- Analysis date
- November 9, 2025
- 5-Amino-1-methylquinolinium content
- 53.85 mg
- Purity
- Not separately reported
GLOW 70 mg
- Batch
- Glow-70
- Analysis date
- April 21, 2026
- GHK-Cu (GHK content) content
- 45.17 mg
- BPC-157 content
- 11.95 mg
- TB-500 (TB4) content
- 11.55 mg
- Purity
- Not separately reported
BPC-157 10 mg
- Batch
- BPC-10
- Analysis date
- April 20, 2026
- BPC-157 content
- 10.62%
- Purity
- 99.036%
SNAP-8 10 mg
- Batch
- 2026-02
- Analysis date
- February 3, 2026
- SNAP-8 content
- 11.85 mg
- Purity
- 99.747%
Pinealon 10 mg
- Batch
- 02/2026
- Analysis date
- February 3, 2026
- Pinealon content
- 12.36 mg
- Purity
- 99.87%
AHK-Cu 50 mg
- Batch
- 5/2026
- Analysis date
- February 3, 2026
- AHK-CU content
- 55.25 mg
- Purity
- 99.89%